PMC:7536954 / 607-937
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T14 | 38-56 | Disease | denotes | drug‐induced lupus | http://purl.obolibrary.org/obo/MONDO_0016474 |
T15 | 51-56 | Disease | denotes | lupus | http://purl.obolibrary.org/obo/MONDO_0004670 |
T16 | 93-95 | Disease | denotes | HS | http://purl.obolibrary.org/obo/MONDO_0006559 |
T17 | 101-104 | Disease | denotes | SLE | http://purl.obolibrary.org/obo/MONDO_0007915 |
T18 | 212-220 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T19 | 258-260 | Disease | denotes | HS | http://purl.obolibrary.org/obo/MONDO_0006559 |
T20 | 265-268 | Disease | denotes | SLE | http://purl.obolibrary.org/obo/MONDO_0007915 |
T21 | 283-291 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T22 | 292-301 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 2-5 | http://purl.obolibrary.org/obo/PR_000000134 | denotes | TNF |
T11 | 125-130 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 8-18 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T6 | 38-42 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T7 | 93-95 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056 |
T8 | 125-130 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
T9 | 258-260 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
31 | 2-7 | Gene | denotes | TNF‐α | Gene:7124 |
32 | 245-252 | Species | denotes | patient | Tax:9606 |
42 | 101-104 | Disease | denotes | SLE | MESH:D008180 |
43 | 212-220 | Disease | denotes | COVID‐19 | MESH:C000657245 |
44 | 265-268 | Disease | denotes | SLE | MESH:D008180 |
45 | 283-291 | Disease | denotes | COVID‐19 | MESH:C000657245 |
46 | 292-301 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T10 | 93-95 | Phenotype | denotes | HS | http://purl.obolibrary.org/obo/HP_0040154 |
T11 | 101-104 | Phenotype | denotes | SLE | http://purl.obolibrary.org/obo/HP_0002725 |
T12 | 258-260 | Phenotype | denotes | HS | http://purl.obolibrary.org/obo/HP_0040154 |
T13 | 265-268 | Phenotype | denotes | SLE | http://purl.obolibrary.org/obo/HP_0002725 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 58-230 | Sentence | denotes | 1 Thus, the unique association of HS with SLE may require the off‐label use of immune‐targeted therapies that is cautiously monitored during the current COVID‐19 pandemic. |